Compare IDEXX Laboratories, Inc. (IDXX) vs Direxion Daily 20 Year Treasury Bull 3X Shares (TMF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Direxion Daily 20 Year Treasury Bull 3X Shares — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while Direxion Daily 20 Year Treasury Bull 3X Shares trades at $26.01 (market cap $2.03B). The key difference: IDEXX Laboratories, Inc. is far larger — about 19.9× Direxion Daily 20 Year Treasury Bull 3X Shares's market cap, and IDEXX Laboratories, Inc. is more actively traded (692,164 versus 12,241,664). Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Direxion Daily 20 Year Treasury Bull 3X Shares for 28 Days on average.
| IDXX | TMF | |
|---|---|---|
Market Cap | $40.43B | $2.03B |
Volume | 692,164 | 12,241,664 |
Sector | Health | Fixed Income |
52-Week High | $766.68 | $44.14 |
52-Week Low | $504.70 | $25.19 |
Typical Hold Time | 46 Days | 28 Days |
Enterprise Value | $41.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $518.00, up 2.24% with strong earnings beats in recent quarters. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and product expansions highlight growth initiatives. Analyst consensus remains bullish with a $665 price target, though technical indicators suggest near-term caution.
Outlook remains positive driven by diagnostic innovation and recurring revenue growth, but faces headwinds from FX volatility and weaker U.S. vet visits. The 36.06 P/E ratio reflects premium valuation, requiring sustained execution. Risks include competitive pressures and insider selling, while institutional ownership trends show mixed signals.
TMF (Direxion Daily 20+ Year Treasury Bull 3X ETF) trades at $25.99, up 3.01% with increased trading volume. Technical indicators show a bearish trend with moving averages signaling caution, while oscillators remain neutral. The ETF saw strong trading volume of 5.25 million shares, indicating heightened investor interest in long-term Treasury exposure.
As a leveraged Treasury ETF, TMF offers amplified exposure to long-term bond performance but carries significant volatility risks. Current market conditions suggest cautious positioning given bearish technical signals and interest rate sensitivity. The dividend payment scheduled for September 2026 provides modest income potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Direxion Daily 20 Year Treasury Bull 3X Shares
TMF is a leveraged ETF that seeks to provide 300% (3x) of the daily performance of the ICE U.S. Treasury 20+ Year Bond Index. It is a tactical instrument used by sophisticated traders to capitalize on declining interest rates or to hedge against equity market volatility. Due to its daily reset mechanism and high expense ratio, TMF is structurally designed for short-term speculation rather than long-term buy-and-hold investing.
Read more on TMF →
